Production and upregulation of granulocyte chemotactic protein-2/CXCL6 by IL-1β and hypoxia in small cell lung cancer
2006
GCP-2 in Small Cell Lung Cancer
Sample size: 9
publication
Evidence: moderate
Author Information
Author(s): Zhu Y M, Bagstaff S M, Woll P J
Primary Institution: University of Sheffield
Hypothesis
Small cell lung cancer (SCLC) cells might produce alternative pro-angiogenic factors.
Conclusion
SCLC cells secrete GCP-2, which can be significantly upregulated by IL-1β and hypoxia, suggesting its role in tumor progression.
Supporting Evidence
- SCLC cells constitutively secrete GCP-2, while NSCLC cells do not.
- GCP-2 production was confirmed in 7 out of 9 SCLC patient specimens.
- IL-1β significantly increased GCP-2 release in SCLC cell lines.
- Hypoxia upregulated GCP-2 production in all tested SCLC cell lines.
Takeaway
This study found that a protein called GCP-2 is made by small cell lung cancer cells, which helps them grow and spread, especially when there's not much oxygen.
Methodology
The study used various SCLC and NSCLC cell lines to measure GCP-2 production through ELISA, Western blotting, and RT-PCR.
Participant Demographics
The study involved 9 SCLC patient specimens.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website